Inventor · disambiguated record
Berthold Wroblowski
Also filed as: WROBLOWSKI BERTHOLD
11 granted patents·3 pending applications·81 citations·filing 2010–2021
87Inventor score
Top patents by PatentIndex Score
14 records- 0195US9850228B2Pyrazolyl quinoxaline kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2016·Granted Dec 26, 2017·17 cites·5 claims
- 0295US9464071B2Pyrazolyl quinoxaline kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2014·Granted Oct 11, 2016·24 cites·45 claims
- 0394US8895601B2Pyrazolyl quinoxaline kinase inhibitorsSAXTY GORDON·Filed 2011·Granted Nov 25, 2014·25 cites·36 claims
- 0490US10519137B2Pyrazolyl quinoxaline kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2017·Granted Dec 31, 2019·6 cites·18 claims
- 0589US8481531B2Bicyclic heterocyclyl derivatives as FGFR kinase inhibitors for therapeutic useSAXTY GORDON·Filed 2010·Granted Jul 9, 2013·9 cites·20 claims
- 0677US2022135544A1Pyrazolyl quinoxaline kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 0768US2020131153A1Pyrazolyl quinoxaline kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 0852US12404260B2Pyridine rings containing derivatives as MALT1 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Sep 2, 2025·0 cites·9 claims
- 0950US12492194B2HPK1 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Dec 9, 2025·0 cites·15 claims
- 1050US12486264B2Bicyclic HPK1 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Dec 2, 2025·0 cites·23 claims
- 1135US8722687B2Imidazo [1,2-A]pyridine derivatives as FGFR kinase inhibitors for use in therapySAXTY GORDON·Filed 2010·Granted May 13, 2014·0 cites·20 claims
- 1233US10017509B2Macrocylic pyrimidine derivativesJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Jul 10, 2018·0 cites·12 claims
- 1333US2017022201A1Macrocylic pyridine derivativesJANSSEN PHARMACEUTICA NV·Filed 2015·Application pending·0 cites
- 1432US10280170B2Substituted 4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyrazine derivatives and 5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a][1,4]diazepine derivatives as Ros1 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted May 7, 2019·0 cites·13 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →